Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsMountain Health Co-Op Formulary Coverage | OpenPay…
    Ask Trek AI about this page
    CurrentMountain Health Co-OpPolicy PHARM-0001

    Non-Formulary Drug Coverage Policy

    Customize your policy alerts

    Sign up for Mountain Health Co-Op Policy PHARM-0001 alerts

    Get alerted when Policy PHARM-0001 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of non-formulary retail medications through a formulary exception based on medical necessity and applies across all lines of business.

    Policy Summary
    PayerMountain Health Co-Op
    PolicyNon-Formulary Drug Coverage Policy
    Policy CodePolicy PHARM-0001
    Change TypeNo material change
    Effective DateN/A
    Last ReviewJul 11, 2025
    Next Review DateJul 11, 2026
    Key ActionSubmit the Mountain Health Co-Op Formulary Exception Request Form with chart notes and clinical documentation supporting medical necessity.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    12 monthsInitial authorization duration
    12 monthsRe-authorization duration
    FDA-approvedRequired indication basis
    1-855-885-7695Exception form call center
    Annual

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy review frequency

    Formulary Exception Coverage Criteria

    Initial formulary exception criteria

    A non-formulary medication may be approved when all applicable requirements are met.

    Initial formulary exception requirements

    • Medical necessity pathway: The member has failed or has a contraindication to all FDA-indicated formulary and/or guideline-recommended options; or the requested therapy has clinically significant superior efficacy compared with formulary options, supported by randomized controlled clinical trials and applicable clinical guidelines; or the requested medication is medically necessary and the only treatment option for the member's condition.

      The applicable pathway must be supported by clinical documentation.

    • Documentation requirements: The provider submits the Formulary Exception Request Form with chart notes and clinical documentation supporting medical necessity. The documented diagnosis must be confirmed by medical records, which may include test reports, provider chart notes, or hospital admission notes.
    • Formulary alternative history: The start date and duration of each formulary alternative are provided, and paid claims are available when the member was enrolled with the Health Plan while receiving the formulary alternative.

      Non-adherence to a formulation requiring multiple daily doses does not by itself establish medical necessity; relevant physical or mental characteristics must be documented.

    Renewal authorization criteria

    Continued coverage requires all applicable renewal requirements to be met.

    Renewal authorization requirements: The member demonstrates a positive clinical response to therapy; pharmacy claims show adherence to the regimen; new formulary products, generics, and biosimilars available since the first authorization have been evaluated and tried when required; and the original authorization and any subsequent renewals were completed appropriately according to the criteria.12-month renewal period

    For members new to the plan, clinical documentation must demonstrate adherence. New generics and biosimilars must be evaluated under the applicable PBM Brand Name Medications Policy or Biosimilar Policy.

    Dosage and regimen criteria

    Dosing and regimen requirements apply to every authorization.

    Dosing and regimen requirements: Dosing must be in accordance with the US Food and Drug Administration-approved package insert. For a dose outside the FDA-approved package insert, the provider must submit supporting documentation, such as published peer-reviewed literature, to request coverage. Accurate member information, dose, and frequency must be submitted. Any change in dose, frequency, or regimen requires a new prior authorization.FDA-approved package insert dosing unless supported by peer-reviewed literature

    Mountain Health Co-Op reserves the right to conduct post-payment reviews and audits of submitted claims.

    Prior use of medication samples is not considered when determining a member’s eligibility for coverage of the requested medication.

    Contraindications identified in the FDA-approved package insert apply when determining coverage eligibility.

    This policy does not supersede drug-specific prior authorization criteria, quantity limits, other utilization-management requirements, or drug or therapeutic category benefit exclusions. These requirements continue to apply to the requested medication.

    Non-adherence to a formulation requiring multiple daily doses does not, by itself, establish medical necessity. The provider must submit chart notes documenting the member’s relevant physical or mental characteristics to support the medical-necessity determination.

    Provider Submission Requirements

    Prior Authorization

    Submit a Formulary Exception Request

    Submit a formulary exception request using the required Formulary Exception Request Form. Include chart notes and clinical documentation supporting the member’s medical necessity for the requested non-formulary medication.

    • Use the Formulary Exception Request Form.
    • Include supporting chart notes and clinical documentation.
    Documentation Required

    Establish Medical Necessity

    The requested medication must have an FDA-approved indication for the member’s condition. Establish medical necessity by documenting failure or contraindication to all FDA-indicated formulary and guideline-recommended options, clinically significant superior efficacy supported by randomized controlled trials and applicable guidelines, or that the medication is the only treatment option.

    • Document the FDA-approved indication.

    Formulary Administration

    Mountain Health Co-Op maintains formulary medication lists that are reviewed and approved by the Pharmacy and Therapeutics Committee and applicable state regulatory bodies. New drugs are evaluated at least quarterly based on clinical necessity, evidence-based literature and guidelines, comparative cost, and member safety.

    Key Terms

    Formulary
    DefinitionA list of medications that are covered under the pharmacy benefit.
    Non-Formulary Drug
    DefinitionA retail drug not covered on the formulary as part of the pharmacy benefit.
    Formulary Exception
    DefinitionA request by a healthcare provider to cover a medication due to medical necessity that is not included in the health plan's formulary.

    Initial Formulary Exception

    Initial formulary exception

    Initial coverage may be approved when all applicable non-formulary medical necessity, formulary alternative, documentation, and formulation-specific requirements are met.

    Initial formulary exception requirements

    • Qualifying medical necessity pathway: The member has failed or has a contraindication to all FDA-indicated formulary and/or guideline-recommended options; or the requested therapy has clinically significant superior efficacy compared with formulary options, supported by randomized controlled clinical trials and applicable clinical guidelines; or the requested medication meets medical necessity and is the only treatment option for the member's condition.
    • Formulary alternative and documentation requirements: The start date and duration of each formulary alternative are provided; paid claims are available when the member was enrolled with the Health Plan while receiving the alternative; the Formulary Exception Request Form, chart notes, and clinical documentation supporting medical necessity are submitted; and the documented diagnosis is confirmed by medical records, which may include test reports, provider chart notes, or hospital admission notes.

    Renewal Authorization

    Renewal authorization

    Renewal authorization requires continued clinical benefit, adherence, and reassessment of available alternatives.

    Continuation therapy requirements: The member shows a positive clinical response to therapy; pharmacy claims demonstrate adherence; new formulary products available since the first approval have been evaluated and tried when appropriate; new generics and biosimilars have been tried when required under the applicable PBM Brand Name Medications Policy or Biosimilar Policy; and the original authorization and any subsequent renewals were completed appropriately according to the criteria.12-month renewal period

    Members new to the plan must provide clinical documentation demonstrating adherence.

    Formulary Alternative Sequencing

    StepRequirementFailure or exception criteria
    1Use indicated formulary medications before requesting coverage of the non-formulary medication.The member must have tried and failed all applicable FDA-indicated formulary and/or guideline-recommended options, unless documentation establishes a contraindication, clinically significant superior efficacy, or that the requested medication is the only medically necessary treatment option.
    StepRequirementTiming and criteria
    2Reassess and use newly available preferred alternatives when appropriate.At renewal, evaluate new formulary products, generics, and biosimilars that became available since the initial authorization; try them when required under the applicable PBM Brand Name Medications Policy or Biosimilar Policy.

    Applicable Reference Biologic

    Billing Rule

    Assess the applicable reference biologic

    At renewal, determine whether newly available biosimilars have been tried according to the applicable Biosimilar Policy.

    Policy Summary
    PayerMountain Health Co-Op
    PolicyNon-Formulary Drug Coverage Policy
    Policy CodePolicy PHARM-0001
    Change TypeNo material change
    Effective DateN/A
    Last ReviewJul 11, 2025
    Next Review DateJul 11, 2026
    Key ActionSubmit the Mountain Health Co-Op Formulary Exception Request Form with chart notes and clinical documentation supporting medical necessity.
    SourceLink
    On This Page
    Formulary Exception Coverage CriteriaProvider Submission RequirementsFormulary AdministrationKey TermsInitial Formulary ExceptionRenewal AuthorizationFormulary Alternative SequencingApplicable Reference Biologic
  1. Document failed or contraindicated formulary and guideline-recommended alternatives, unless another permitted medical-necessity pathway applies.
  2. Drug-specific criteria approved by the P&T Committee take precedence over this policy.
  3. Documentation Required

    Support Special Formulation Requests

    Support requests for special formulations with chart-supported clinical rationale. The record must explain why the member cannot use the active ingredients separately for a combination product or cannot use the formulary immediate-release product for a long-acting formulation.

    • For combination products, explain why the active ingredients cannot be prescribed separately.
    • For long-acting formulations, explain why the formulary immediate-release formulation cannot be used.
    • Non-adherence to a multiple-daily-dose formulation alone does not establish medical necessity; document relevant physical or mental characteristics.

    Unsupported block type: prior_authปassistant to=json_output_schema code_word#+#+#+#+ (json, not commentary) 述json 制定

    Step Therapy

    Try Formulary Alternatives First

    Try indicated formulary alternatives before requesting a non-formulary medication. Each applicable alternative must be tried and failed or be contraindicated, unless a documented medical-necessity exception applies.

    • Document failure or contraindication to all applicable FDA-indicated formulary and guideline-recommended options.
    • Account for drug-specific prior authorization, quantity limits, utilization-management criteria, and benefit exclusions.
    Step Therapy

    Reassess Newer Alternatives at Renewal

    At renewal, reassess whether newer formulary products, generics, or biosimilars are available and more appropriate. Document any required trials under the applicable PBM Brand Name Medications Policy or Biosimilar Policy.

    • Evaluate new formulary products introduced since the original approval.
    • Evaluate new generics and biosimilars and document required trials.
    Prior Authorization

    Formulary Exception Request

    Obtain the Formulary Exception Request Form from www.mountainhealth.coop or by calling the Mountain Health Co-Op prescription drug benefits call center at 1-855-885-7695. Submit the completed form with the required clinical documentation.

    • Form location: www.mountainhealth.coop.
    • Prescription drug benefits call center: 1-855-885-7695.
    Documentation Required

    Medical Necessity and Diagnosis Records

    Supply medical records confirming the documented diagnosis and supporting the request. Records may include test reports, provider office chart notes, or hospital admission notes, together with the clinical rationale and evidence regarding alternatives.

    • Include confirmed diagnoses in the medical records.
    • Include alternative failures or contraindications and the clinical rationale for the requested therapy.
    • Attach relevant test reports, office chart notes, or hospital admission notes.
    Documentation Required

    Formulary Alternative History

    Document the member’s history with each relevant formulary alternative. Include treatment start dates, duration, outcomes, and whether paid claims are available when the member was enrolled with the Health Plan.

    • Provide the start date and duration for formulary alternatives.
    • If the member was enrolled with the Health Plan during treatment, paid claims must be present.
    • For members new to the plan, provide available clinical documentation of prior treatment and adherence.
    Documentation Required

    Formulation-Specific Rationale

    Provide chart-supported reasons for requesting a combination or long-acting formulation rather than the applicable separate-ingredient or immediate-release formulary options. Non-adherence to a formulation requiring multiple daily doses alone does not guarantee medical necessity.

    • Document why combination-product ingredients cannot be taken separately.
    • Document why the immediate-release formulary product cannot be used.
    • Describe relevant physical or mental characteristics when they support the formulation request.
    Documentation Required

    Dosing Documentation

    Document the exact requested dose, frequency, and regimen. FDA-labeled dosing should be supported by the package insert; non-labeled dosing requires supporting documentation such as published peer-reviewed literature.

    • Submit any dose, frequency, or regimen change for a new prior authorization.
    • Ensure member information and regimen details are accurate.
    • Mountain Health Co-Op may conduct post-payment reviews and audits.
    Prior Authorization

    Renewal Documentation

    For renewal, document continued clinical benefit and appropriate use of the therapy. Pharmacy claims should show adherence, and members new to the plan require clinical documentation demonstrating adherence.

    • Document a positive clinical response.
    • Document pharmacy-claims adherence to the regimen.
    • For members new to the plan, provide clinical documentation of adherence.
    • Confirm that the original authorization and subsequent renewals met the applicable criteria.
    Denial Risk

    Formulary Alternatives or Drug-Specific Criteria Not Satisfied

    A request may be denied when required formulary alternatives have not been tried and failed or when applicable drug-specific criteria are not satisfied. Drug-specific P&T Committee criteria take precedence over this non-formulary policy.

    • Document failure or contraindication to each applicable alternative, or a qualifying medical-necessity exception.
    • Meet any drug-specific prior authorization, quantity-limit, utilization-management, or benefit-exclusion requirements.
    Denial Risk

    Insufficient Supporting Documentation

    A request may be denied when the required exception form, chart notes, diagnosis confirmation, or other clinical records are missing or insufficient. Medical records must support the diagnosis, alternative history, and requested therapy’s medical necessity.

    • Submit the Formulary Exception Request Form.
    • Include chart notes and clinical documentation supporting medical necessity.
    • Include records confirming the diagnosis, such as test reports, office notes, or hospital admission notes.
    Denial Risk

    Unapproved Dosing or Contraindication

    Coverage may be denied for dosing outside the FDA-approved package insert without supporting peer-reviewed literature or for inaccurate dose, frequency, or regimen information. Applicable contraindications under the package insert also must be addressed; prior use of samples is not considered for eligibility.

    • Provide published peer-reviewed literature for non-FDA-labeled dosing.
    • Submit a new authorization when the dose, frequency, or regimen changes.
    • Do not rely on sample use to establish eligibility.
    • Review and address contraindications identified in the package insert.
    Denial Risk

    Continuation Criteria Not Met

    Renewal may be denied when the member does not demonstrate a positive clinical response, adherence, or compliance with renewal requirements. Reassess new alternatives and confirm that the original authorization and any subsequent renewals were appropriate under the applicable criteria.

    • Document positive clinical response.
    • Provide pharmacy claims showing adherence, or clinical documentation of adherence for members new to the plan.
    • Evaluate new formulary products, generics, and biosimilars that may be more appropriate.
    • Confirm authorization history and all applicable continuation criteria.
    Formulation requirements when applicable: For a combination product, chart notes provide a clinical reason why the member is unable to take the active ingredients separately, and the individually prescribed medications are provided. For a long-acting formulation, chart notes provide a clinical reason why the member is unable to use the immediate-release formulation of the formulary drug.

    Apply the relevant requirement when the request involves a combination product or long-acting formulation.